Skip to main content
VCbacked
Log inGet Started

Global Blood Therapeutics

South San Francisco, United States

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

$300.0M raised
Dec 2021
Post-IPO Debt
BiotechnologyGeneticsMedicalTherapeutics

Top Investors

RA Capital ManagementWellington ManagementThird Rock VenturesDeerfieldCowen Healthcare Investments

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Global Blood Therapeutics

How much funding has Global Blood Therapeutics raised?
Global Blood Therapeutics has raised $300.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in December 2021.
Who are Global Blood Therapeutics's investors?
Global Blood Therapeutics's investors include RA Capital Management, Wellington Management, Third Rock Ventures, Deerfield, Cowen Healthcare Investments.
Where is Global Blood Therapeutics headquartered?
Global Blood Therapeutics is headquartered in South San Francisco, United States.
What does Global Blood Therapeutics do?
GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.
What stage is Global Blood Therapeutics at?
Global Blood Therapeutics is at the Post-IPO Debt stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Global Blood Therapeutics — Funding & Investors." VCBacked, December 15, 2021, https://www.vcbacked.co/company/global-blood-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2021). Global Blood Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/global-blood-therapeutics
Wikipedia (cite web)
{{cite web |title=Global Blood Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/global-blood-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K